Literature DB >> 27682709

Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.

Nurullah Çelik, Peyami Cinaz, Aysun Bideci, Betül Derinkuyu, Hamdi Cihan Emeksiz, Esra Döğer, Çağrı Damar, Özge Yüce, Orhun Çamurdan.   

Abstract

BACKGROUND: The aim of this study was to investigate the early signs of atherosclerosis and to evaluate serum endoglin and obestatin levels as predictors of subclinical atherosclerosis in obese children.
METHODS: A total of 95 children (60 obese and 35 controls) aged 10-18 years were included in the study. Their endoglin and obestatin levels and biochemical parameters were measured. The carotid intima media thickness (cIMT) and brachial artery flow-mediated dilatation (FMD) responses were evaluated.
RESULTS: The cIMT values were higher (p < 0.001) and FMD responses were lower (p = 0.003) in the obese group than in the control group. A logistic regression multivariate analysis revealed that cIMT was independently associated with the body mass index (BMI) Z-score (β = 0.323, p = 0.003) and low density lipoprotein (LDL) (β = 0.29, p = 0.008), while FMD % was independently associated with waist circumference (β = -0.36, p = 0.002). The obese and control groups were similar in endoglin (p = 0.67) and obestatin levels (p = 0.70). The endoglin level was inversely correlated with the cholesterol and LDL levels (r = -0.23, p = 0.032; rho = -0.25, p = 0.019).
CONCLUSIONS: The cIMT and brachial artery FMD response in obese children are significantly different compared to healthy controls. Circulating endoglin and obestatin levels are not predictive markers for subclinical atherosclerosis in obese children aged 10-18 years old.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27682709     DOI: 10.1515/jpem-2016-0024

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition.

Authors:  Qiaowei Li; Fan Lin; Douli Ke; Qiong Cheng; Yongzhi Gui; Yuyan Zhou; Yicheng Wu; Yinzhou Wang; Pengli Zhu
Journal:  J Atheroscler Thromb       Date:  2019-08-09       Impact factor: 4.928

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.